Mucinex Acquisition Nothing to Sneeze At

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Reckitt Benckiser’s increased marketing spend and acquisition of Adams Respiratory made for some healthy earnings for the first half of the year. RB reported that its net revenues increased 11% ($6.1 billion). Growth was driven by higher investment in RB’s 17 Powerbrands, including Lysol, Calgon and Woolite, as well as the successful rollout of Airwick Symphonia.

The company noted that its marketing investment was significantly higher for the period. Pure media investment increased 25% to a level of 13.5%

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in